CD8A and neoplasm: dMMR/MSI colorectal cancers are hypermutated and generate abundant mutation-derived neoantigens, which elicit robust immune responses, particularly through increased infiltration of CD8+ tumor-infiltrating lymphocytes (TIL) within the tumor microenvironment (TME; refs. 4, 5).